3billion
3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as … Read more
3billion (394800) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.145x
Based on the latest financial reports, 3billion (394800) has a cash flow conversion efficiency ratio of -0.145x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.10 Billion) by net assets (₩28.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
3billion - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how 3billion's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
3billion Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 3billion ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Canoe EIT Income Fund
PINK:ENDTF
|
-0.028x |
|
COZX
BATS:COZX
|
N/A |
|
Invesco Pennsylvania Value Municipal Income Trust
NYSE:VPV
|
0.021x |
|
Lake Superior Acquisition Corp. Class A Ordinary Shares
NASDAQ:LKSP
|
N/A |
|
Chicago Atlantic BDC, Inc.
NASDAQ:LIEN
|
0.000x |
|
DP Cap Acquisition Corp I Warrants
NASDAQ:DPCSW
|
-0.032x |
|
ORVR3F
SA:ORVR3F
|
N/A |
|
DRAX GROUP - Dusseldorf Stock Exchang
DU:D9F2
|
N/A |
Annual Cash Flow Conversion Efficiency for 3billion (2021–2024)
The table below shows the annual cash flow conversion efficiency of 3billion from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩28.27 Billion | ₩-4.10 Billion | -0.145x | +64.91% |
| 2023-12-31 | ₩11.79 Billion | ₩-4.87 Billion | -0.414x | -5.18% |
| 2022-12-31 | ₩16.31 Billion | ₩-6.41 Billion | -0.393x | -58.84% |
| 2021-12-31 | ₩18.71 Billion | ₩-4.63 Billion | -0.248x | -- |